BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 28399267)

  • 1. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.
    Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
    J Pharm Sci; 2012 Feb; 101(2):616-26. PubMed ID: 21989812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ
    Taskar PS; Patil A; Lakhani P; Ashour E; Gul W; ElSohly MA; Murphy B; Majumdar S
    Transl Vis Sci Technol; 2019 Sep; 8(5):15. PubMed ID: 31588378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations.
    Hingorani T; Adelli GR; Punyamurthula N; Gul W; Elsohly MA; Repka MA; Majumdar S
    Pharm Res; 2013 Aug; 30(8):2146-56. PubMed ID: 23737345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of surfactant concentration and sterilization process on intraocular pressure-lowering activity of Δ
    Sweeney C; Dudhipala N; Thakkar R; Mehraj T; Marathe S; Gul W; ElSohly MA; Murphy B; Majumdar S
    Drug Deliv Transl Res; 2021 Oct; 11(5):2096-2107. PubMed ID: 33169348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.
    Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M; Nair S; Rui E; Lafontaine J; Almaden CD; Wells P; Krauss A
    Exp Eye Res; 2009 Nov; 89(5):608-17. PubMed ID: 19445930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure.
    Lorenzo-Soler L; Olafsdottir OB; Garhöfer G; Jansook P; Kristinsdottir IM; Tan A; Loftsson T; Stefansson E
    Acta Ophthalmol; 2021 Jun; 99(4):376-382. PubMed ID: 33191620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
    Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
    Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
    Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
    J Oleo Sci; 2010; 59(8):423-30. PubMed ID: 20625234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
    Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.
    Hippalgaonkar K; Gul W; ElSohly MA; Repka MA; Majumdar S
    AAPS PharmSciTech; 2011 Jun; 12(2):723-31. PubMed ID: 21637944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analog Derivatization of Cannabidiol for Improved Ocular Permeation.
    Taskar P; Adelli G; Patil A; Lakhani P; Ashour E; Gul W; ElSohly M; Majumdar S
    J Ocul Pharmacol Ther; 2019 Jun; 35(5):301-310. PubMed ID: 30998110
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular penetration of topical Delta9-tetrahydrocannabinol from rabbit corneal or cul-de-sac application site.
    Green KE; Kearse CE
    Curr Eye Res; 2000 Jul; 21(1):566-70. PubMed ID: 11035538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits.
    Acheampong AA; Breau A; Shackleton M; Luo W; Lam S; Tang-Liu DD
    J Ocul Pharmacol Ther; 1995; 11(4):489-502. PubMed ID: 8574812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
    Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WK; Gale DC; Kucera DJ; Jia L; Prasanna G; Ongini E; Krauss AH; Impagnatiello F
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):125-32. PubMed ID: 20415621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.